| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Hansen Gwenn is a Chief Scientific Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $35.00 | $14,000.00 | -2.7% | -42.6% | -64.0% | |
| Oct 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $29.92 | $11,968.00 | -2.7% | -4.0% | -58.3% | |
| Sep 7, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,600 | $35.00 | $56,000.00 | -10.1% | -21.2% | -54.2% | |
| Sep 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $32.34 | $12,936.00 | -2.7% | -9.8% | -48.7% | |
| Aug 2, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $31.21 | $12,484.00 | -2.8% | +8.1% | -48.1% | |
| Jul 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $26.76 | $10,704.00 | -2.8% | +6.8% | -51.7% | |
| Jun 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $27.74 | $11,096.00 | -2.8% | +16.9% | -66.6% | |
| May 3, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 800 | $35.00 | $27,996.00 | -5.5% | -5.3% | -66.7% | |
| Apr 5, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $35.00 | $14,000.00 | -2.8% | -33.1% | -59.7% | |
| Apr 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $31.55 | $12,620.00 | -2.8% | -14.5% | -55.0% |